← Back
$LCTX All transactions

Lineage Cell Therapeutics, Inc.

F

$ Value

$109

Shares

65

Price

$2

Filed

Dec 19

Insider

Name

Samuel George A. III

Title

General Counsel and Secretary

CIK

0001878732

Roles

Officer

Transaction Details

Transaction Date

2025-12-19

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

27,490

Footnotes

Shares earned by the Reporting Person upon the vesting of a portion of restricted stock units ("RSUs") granted to the Reporting Person on February 11, 2022 the vesting of which was subject to the achievement of certain performance conditions. RSUs are settled in common shares on a one-for-one basis. | Does not include RSUs that may be settled in the issuer's common shares that have not vested as of the date hereof nor common shares that may be acquired upon the exercise of certain stock options outstanding as of the date hereof. | Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 1,735 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

Filing Info

Accession No.

0001193125-25-327279

Form Type

4

Issuer CIK

0000876343

Samuel George A. III's History

Date Ticker Type Value
2026-03-05 LCTX A $0
2026-02-11 LCTX M
2026-02-11 LCTX F $5K
2026-02-11 LCTX M $0
2025-12-19 LCTX A
2025-12-19 LCTX F $109

Other Insiders at LCTX (90d)

Insider Bought Sold Last
Culley Brian M
President and CEO
$24K 2026-03-12
Samuel George A. III
General Counsel and Secretary
2026-03-05
Howe Jill Ann
Chief Financial Officer
2026-03-05